Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.
Kantarjian H, Haddad FG, Jain N, Sasaki K, Short NJ, Loghavi S, Kanagal-Shamanna R, Jorgensen J, Khouri I, Kebriaei P, Alvarado Y, Kadia T, Paul S, Garcia-Manero G, Dabaja B, Yilmaz M, Jacob J, Garris R, O'Brien S, Ravandi F, Jabbour E.
Kantarjian H, et al. Among authors: short nj.
J Hematol Oncol. 2023 May 2;16(1):44. doi: 10.1186/s13045-023-01444-2.
J Hematol Oncol. 2023.
PMID: 37131217
Free PMC article.
Clinical Trial.